Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

More articles from Article

  • Open Access
    Biomarker Expression Profiling in Cervix Carcinoma Biopsies Unravels WT1 as a Target of Artesunate
    MOHAMED E. M. SAEED, CANDELA CIVES-LOSADA and THOMAS EFFERTH
    Cancer Genomics & Proteomics November 2022, 19 (6) 727-739; DOI: https://doi.org/10.21873/cgp.20355
  • Open Access
    Oral Installation of Recombinant Methioninase-producing Escherichia coli into the Microbiome Inhibits Colon-cancer Growth in a Syngeneic Mouse Model
    YUTARO KUBOTA, QINGHONG HAN, KAZUYUKI HAMADA, YUSUKE AOKI, NORIYUKI MASAKI, KOYA OBARA, ANTON BARANOV, MICHAEL BOUVET, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics November 2022, 19 (6) 683-691; DOI: https://doi.org/10.21873/cgp.20351
  • Open Access
    Derivative Chromosome 3 Loss from t(3;6)(q12;q14) Followed by Differential VHL Mutations Underlie Multifocal ccRCC
    KOSUKE MIZUTANI, SHIGEAKI YOKOI, SEIYA SAWADA, IPPEI SAKAMOTO, KOJI KAMEYAMA, SHINGO KAMEI, KOUSEKI HIRADE, SEIJI SUGIYAMA, KENGO MATSUNAGA, TETSUYA YAMADA, YASUTAKA KATO, HIROSHI NISHIHARA, SATOSHI ISHIHARA and TAKASHI DEGUCHI
    Cancer Genomics & Proteomics November 2022, 19 (6) 740-746; DOI: https://doi.org/10.21873/cgp.20356
  • Open Access
    TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
    GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO
    Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
  • Open Access
    Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells
    TIN MAY AUNG, ATIT SILSIRIVANIT, APINYA JUSAKUL, WARAPORN CHAN-ON, TANAKORN PROUNGVITAYA, SITTIRUK ROYTRAKUL and SIRIPORN PROUNGVITAYA
    Cancer Genomics & Proteomics July 2022, 19 (4) 490-502; DOI: https://doi.org/10.21873/cgp.20335
  • Open Access
    Protein Expression Profiling and Virtual Drug Screening as an Approach for Individualized Therapy of Small Cell Vaginal Carcinoma
    MOHAMED E.M. SAEED, HASSAN E. KHALID, SAILESH K. THAKUR and THOMAS EFFERTH
    Cancer Genomics & Proteomics July 2022, 19 (4) 512-525; DOI: https://doi.org/10.21873/cgp.20337
  • Open Access
    Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling
    MOSTAFA KOKABEE, XIANHUI WANG, ELENA VOORAND, EDEN ALIN, LEILA KOKABEE, FAIZA KHAN, SOPHIA DESROSIERS and DOUGLAS S. CONKLIN
    Cancer Genomics & Proteomics July 2022, 19 (4) 415-427; DOI: https://doi.org/10.21873/cgp.20329
  • Open Access
    Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A Second Case
    IOANNIS PANAGOPOULOS, LUDMILA GORUNOVA, KRISTIN ANDERSEN, MARIUS LUND-IVERSEN, HANNE REGINE HOGNESTAD, INGVILD LOBMAIER, FRANCESCA MICCI and SVERRE HEIM
    Cancer Genomics & Proteomics July 2022, 19 (4) 445-455; DOI: https://doi.org/10.21873/cgp.20331
  • Open Access
    Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases
    HAN GYEOL KIM, HYUNJIN KIM, MIN-KYUNG YEO, KYU YEOUN WON, YOUNG SUN KIM, GWAN HEE HAN, HYUN-SOO KIM and KIYONG NA
    Cancer Genomics & Proteomics July 2022, 19 (4) 526-539; DOI: https://doi.org/10.21873/cgp.20338
  • Open Access
    The Contribution of PDCD6 Polymorphisms to Oral Cancer Risk
    LIANG-CHUN SHIH, JIE-LONG HE, WEN-SHIN CHANG, CHE-LUN HSU, TE-CHUN HSIA, YUN-CHI WANG, JIA-SING YANG, MEI-CHIN MONG, CHIA-WEN TSAI and DA-TIAN BAU
    Cancer Genomics & Proteomics July 2022, 19 (4) 456-463; DOI: https://doi.org/10.21873/cgp.20332

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire